This invention is directed to compounds of the following formula (I): ##STR00001## wherein R is either: ##STR00002## wherein R.sub.1 and R.sub.2 are as defined in the specification; the use of these compounds for treating inflammatory disorders; and pharmaceutical compositions comprising a therapeutically effective amount of the above-defined compounds.